MERCK'S FOSAMAX PATENT UPHELD Merck v. Teva Pharms. USA | Secondary Sources | Westlaw

MERCK'S FOSAMAX PATENT UPHELD Merck v. Teva Pharms. USA | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, MERCK'S FOSAMAX PATENT UPHELD Merck v. Teva Pharms. USA, Secondary Sources
Skip Page Header

MERCK'S FOSAMAX PATENT UPHELD Merck v. Teva Pharms. USA

9 No. 14 ANIPLR 3Andrews Intellectual Property Litigation Reporter (Approx. 2 pages)

MERCK'S FOSAMAX PATENT UPHELD Merck v. Teva Pharms. USA

9 No. 14 ANIPLR 3Andrews Intellectual Property Litigation Reporter (Approx. 2 pages)

9 No. 14 Andrews Intell. Prop. Litig. Rep. 3
Andrews Intellectual Property Litigation Reporter
November 12, 2002
Patent Infringement:
Copyright (c) 2002 Andrews Publications

MERCK'S FOSAMAX PATENT UPHELD

Merck v. Teva Pharms. USA

Merck & Co. has prevailed against two companies seeking to market generic versions of its osteoporosis drug Fosamax, winning a judgment that its patent would be infringed by the generic compounds. Merck & Co. v. Teva Pharmaceuticals USA Inc. et al.,...
End of Document© 2023 Thomson Reuters. No claim to original U.S. Government Works.